PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Hoyoku Nishino Selected Research
Neoplasms (Cancer)
01/2008
Anti-tumor-Promoting activity of tibolone and its metabolites.
09/2007
Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
08/2007
Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects.
06/2007
Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.
06/2007
Triterpene acids from Poria cocos and their anti-tumor-promoting effects.
01/2006
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
01/2006
Potential cancer chemopreventive activity of simple isoquinolines, 1-benzylisoquinolines, and protoberberines.
11/2005
Tumor suppressive effects of tocotrienol in vivo and in vitro.
11/2005
Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells.
10/2005
Anti-tumor-initiating effects of monascin, an azaphilonoid pigment from the extract of Monascus pilosus fermented rice (red-mold rice).
08/2005
The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells.
07/2005
Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters.
03/2005
Chemical constituents of Murraya siamensis: three coumarins and their anti-tumor promoting effect.
07/2004
Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
03/2004
Cancer chemopreventive effects of polyunsaturated fatty acids.
02/2004
Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models.
01/2004
Cancer prevention by antioxidants.
07/2003
Cancer chemopreventive effects of oral feeding alpha-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse.
06/2003
H-ras mutations at codon 61 or 13 in tumors initiated with a NO donor in mouse skin.
06/2003
Cancer preventive potential of trichothecenes from Trichothecium roseum.
05/2003
Isolation, structural elucidation, and inhibitory effects of terpenoid and lipid constituents from sunflower pollen on Epstein-Barr virus early antigen induced by tumor promoter, TPA.
04/2003
Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.
03/2003
Synthesis and anti-tumor-promoting activity of glycoglycerolipid analogues lacking the glycerol backbone.
03/2003
Chemical constituents of Calophyllum brasiliense. 2. Structure of three new coumarins and cancer chemopreventive activity of 4-substituted coumarins.
02/2003
Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot.
02/2003
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
02/2003
Chemical constituents of Garcinia fusca: structure elucidation of eight new xanthones and their cancer chemopreventive activity.
02/2003
Anti-tumor promoting effect of glycosides from Prunus persica seeds.
11/2002
Inhibitory effects of cucurbitane glycosides and other triterpenoids from the fruit of Momordica grosvenori on epstein-barr virus early antigen induced by tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
06/2002
Cancer chemopreventive effects of a Brazilian folk medicine, Juca, on in vivo two-stage skin carcinogenesis.
04/2002
Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos.
03/2002
Microbial transformations of two lupane-type triterpenes and anti-tumor-promoting effects of the transformation products.
03/2002
Chemical constituents of Calophyllum brasiliensis: structure elucidation of seven new xanthones and their cancer chemopreventive activity.
02/2002
Cancer chemopreventive activity of flavanones on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.
02/2002
Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor-promotion.
02/2002
Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica.
02/2002
Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis.
01/2002
Carotenoids in cancer chemoprevention.
Articles by Research Topic
Disease
38
Neoplasms (Cancer)
01/2008 - 01/2002
4
Osteonecrosis (Kienbock's Disease)
05/2007 - 11/2003
2
Colonic Neoplasms (Colon Cancer)
06/2007 - 01/2006
2
Prostatic Neoplasms (Prostate Cancer)
11/2004 - 05/2003
1
Inflammation
11/2005
1
Hepatocellular Carcinoma (Hepatoma)
11/2005
1
Lung Neoplasms (Lung Cancer)
04/2004
1
Neoplasm Metastasis (Metastasis)
09/2002
1
Renal Cell Carcinoma (Grawitz Tumor)
09/2002
Drug/Important Bio-Agent (IBA)
5
isoliquiritigenin (GU 17)
IBA
01/2006 - 02/2002
3
cucurbitane
IBA
08/2007 - 02/2002
3
Epstein-Barr virus early antigen
IBA
02/2004 - 11/2002
3
Glycosides
IBA
02/2003 - 02/2002
2
Acids
IBA
06/2007 - 04/2002
2
Luteolin
IBA
11/2005 - 08/2005
2
Coumarins
IBA
03/2005 - 03/2003
2
Xanthones
IBA
02/2003 - 03/2002
2
Triterpenes
IBA
04/2002 - 03/2002
1
tibolone
IBA
01/2008
1
sesamin
IBA
09/2007
1
Cyclin D1
IBA
09/2007
1
halocynthiaxanthin
IBA
06/2007
1
peridinin
IBA
06/2007
1
cycloartane
IBA
06/2007
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2007
1
Apolipoproteins B (ApoB)
IBA
05/2007
1
Apolipoproteins A
IBA
03/2007
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2006
1
Isoquinolines
IBA
01/2006
1
Chalcones
IBA
01/2006
1
Tocotrienols
IBA
11/2005
1
DNA (Deoxyribonucleic Acid)
IBA
11/2005
1
Biological Markers (Surrogate Marker)
IBA
11/2005
1
RNA (Ribonucleic Acid)
IBA
11/2005
1
TANDEM
IBA
11/2005
1
Nucleosides
IBA
11/2005
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
11/2005
1
Glycyrrhetinic Acid (Po 12)
IBA
11/2005
1
monascin
IBA
10/2005
1
2-phenyl-4-oxohydroquinoline
IBA
07/2005
1
9-oxo-9,10-dihydroacridine
IBA
07/2005
1
Genistein
IBA
11/2004
1
Protein Kinase C
IBA
07/2004
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
03/2004
1
Phenothiazines
IBA
02/2004
1
Antioxidants
IBA
01/2004
1
alpha-Tocopherol
FDA Link
07/2003
1
Codon (Codons)
IBA
06/2003
1
Trichothecenes
IBA
06/2003
1
Alkaloids
IBA
04/2003
1
acridone
IBA
04/2003
1
Glycerol (Glycerine)
FDA Link
Generic
03/2003
1
glycerolglycolipids
IBA
03/2003
1
Benzophenones
IBA
02/2003
1
Phenobarbital (Luminal)
FDA Link
02/2003
1
9,10-Dimethyl-1,2-benzanthracene (DMBA)
IBA
02/2003
1
lupane
IBA
03/2002
1
Flavanones
IBA
02/2002
1
7-isopentenyloxycoumarin
IBA
02/2002
1
Azoxymethane
IBA
02/2002
1
coumarin
IBA
02/2002
1
Carotenoids (Carotene)
IBA
01/2002
Therapy/Procedure
4
Chemoprevention
02/2003 - 01/2002
2
Kidney Transplantation
05/2007 - 11/2003
2
Transplants (Transplant)
03/2007 - 01/2004
1
Traditional Medicine (Folk Remedies)
06/2002